Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth
Nature Medicine2009Vol. 15(9), pp. 1023–1030
Citations Over TimeTop 1% of 2009 papers
Romulo Albuquerque, Takahiko Hayashi, Won Gil Cho, Mark E. Kleinman, Sami Dridi, Atsunobu Takeda, Judit Baffi, Kiyoshi Yamada, Hiroki Kaneko, Martha G. Green, Joe Chappell, Jörg Wilting, Herbert A. Weich, Satoru Yamagami, Shiro Amano, Nobuhisa Mizuki, J. Steven Alexander, Martha L. Peterson, Rolf A. Brekken, Masanori Hirashima, Seema Capoor, Tomohiko Usui, Balamurali K. Ambati, Jayakrishna Ambati
Related Papers
- → TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling(2014)189 cited
- → Induction of lymphangiogenesis through vascular endothelial growth factor-C/vascular endothelial growth factor receptor 3 axis and its correlation with lymph node metastasis in nasopharyngeal carcinoma(2012)31 cited
- Expression of lymphatic vessel hyaluronan receptor-1 and vascular endothelial growth factor recep- tor-3 in gastric cancer(2009)
- → Relationship between lymphangiogenesis and lymphatic vessel density in gastric carcinoma(2008)
- → Data from Vascular Endothelial Growth Factor-A Promotes Peritumoral Lymphangiogenesis and Lymphatic Metastasis(2023)